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S U M M A R Y
Melioidosis is an important disease in Asia and Australia. It is very rare in Venezuela.We describe the case
of a 50-year-old diabetic patient with several episodes of right tibial osteomyelitis, left shoulder arthritis,
sternal osteomyelitis, right parietal osteomyelitis, and subperiosteal abscess, followed by septic arthritis
of the right knee. In all cases Gram stain smear showed Gram-negative bacilli. Culture yielded
Burkholderia pseudomallei, susceptible to third- and fourth-generation cephalosporins, ciproﬂoxacin and
aztreonam, and resistant to aminoglycosides. He developed sepsis syndrome. Blood cultures and culture
of abscess and joint ﬂuids also revealed B. pseudomallei. The patient was treated with ceftazidime and
ciproﬂoxacin, then cefepime and trimethoprim–sulfamethoxazole. He was discharged with suppressive
therapy consisting of oral doxycycline and trimethoprim–sulfamethoxazole, and follow-up has
continued to date. At this time he remains asymptomatic. Melioidosis is an extremely rare disease in
our country. To our knowledge, this is only the second case reported in Venezuela.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Melioidosis is a disease of public health importance in
Southeast Asia and northern Australia, which has the potential
for epidemic spread to areas where it is not endemic.1 The three
main modes of acquisition of this agent are inhalation, ingestion,
and inoculation. Other unusualmodes of transmission described in
case reports include person-to-person, sexual, perinatal, vertical,
and nosocomial.1
Melioidosis is a fascinating infection in terms of its pathogene-
sis. The outcome of the host–pathogen interaction ranges from
asymptomatic seroconversion to rapidly fatal, overwhelming
sepsis. Between these extremes the infection may run a chronic
or relapsing course, or may remain latent for long periods of time
before declaring itself. It has been proposed as a model of Gram-
negative sepsis, but the organismdiffers fromother Gram-negative§ This case was presented as a poster (No. 58.026) at the 11th International
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severity of acute melioidosis indicates that it has potent virulence
factors, and themost important are the polysaccharide capsule and
lipopolysaccharide. They mediate resistance to complement-
mediated killing.1
Several studies have reported risk factors for this disease, and
they are well known.1,2 Clinical presentations include the
bacteremic form, with or without septic shock, and the non-
bacteremic form, including pneumonia, genitourinary and soft
tissue infections, osteomyelitis, and others.1–3 Treatment in the
intensive care unitwith third- or fourth-generation cephalosporins
and carbapenems, followed by eradication therapy with trimetho-
prim–sulfamethoxazolewith orwithout tetracyclines is associated
with decreased mortality.1
We report a case of melioidosis presenting as sepsis syndrome
occurring in Caracas, Venezuela.
2. Case report
We report the case of a 50-year-old diabetic patient from
Maracay (50 miles from Caracas), who was an electricity worker in
the rice plantations. His prior history consisted of non-insulin-
dependent diabetes with irregular treatment and right tibialses. Published by Elsevier Ltd. All rights reserved.
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Pseudomonas sp, treated with multiple antibiotics, which he
completed for 3 months. In 1999 he developed arthritis in the
left shoulder and underwent surgery. Joint surgical debridement
was performed, with no culture. Actinomycosis was suspected and
the patient was treated with high-dose penicillin.
In September 2000, he was admitted with sternal osteomyelitis,
presenting secretion of yellow pus in the sternal area. His
erythrocyte sedimentation rate was 70 mm/h. Liver enzymes were:
total bilirubin 6.6 mg/dl, with direct bilirubin 5.6 mg/dl, alanine
aminotransferase 105 mg/dl, and aspartate aminotransferase
80 mg/dl. A Gram stain smear showed Gram-negative bacilli.
Culture yielded Burkholderia pseudomallei, susceptible only to third-
andfourth-generationcephalosporins, ciproﬂoxacinandaztreonam,
and resistant to aminoglycosides. He was started on therapy with
intravenous (IV) ceftazidime and ciproﬂoxacin for 3 weeks. He was
discharged on 6-week therapy with IV cefepime plus oral
ciproﬂoxacin. Follow-up continued until September 2002, when
hewas admittedwith right parietal osteomyelitis and subperiosteal
abscess, followed by septic arthritis of the right knee. He developed
sepsis syndromewithpale skin, tachycardia, tachypnea, hypoxemia,
mental status alterations, and gastrointestinal bleeding. He under-
went surgery for drainage of the abscess and debridement of the
osteomyelitis and septic arthritis. Blood cultures and culture of
abscess and joint ﬂuids revealed B. pseudomallei, susceptible to
cefepime, ceftazidime and imipenem, and resistant to aminoglyco-
sides and ciproﬂoxacin. He was started on IV cefepime and IV
trimethoprim–sulfamethoxazole. Suppressive therapy consisting of
oral doxycycline (100 mgevery 12 h) and trimethoprim–sulfameth-
oxazole (1double strength tablet every12 h)was given for 1 year. At
this time he remains asymptomatic.
3. Discussion
Melioidosis is endemic in Southeast Asia and northern
Australia. In parts of northeastern Thailand, it is the most common
cause of severe community-acquired sepsis.1 The ﬁrst reported
case in the northern territory of Australia occurred in 1960 and
melioidosis is now recognized as the most common cause of fatal
community–acquired bacteremic pneumonia.1 In several pub-
lished series, pneumonia is the most frequent presentation of
melioidosis and is involved in approximately half of all cases.1–3
In Venezuela, only one case has been reported, although it was
never published. In 1995 Marin et al. described a case of
necrotizing pneumonia diagnosed by bronchoscopy, in which
culture yielded B. pseudomallei.4
In our report, co-morbidity, occupation and age were most
relevant. The patient was a diabetic 50-year-old man, who had
been an electrician in a rice plantation for several years.
B. pseudomallei is visualized as a slender Gram-negative bacillus
with rounded ends and bipolar staining, and is vacuolated; it is
often described as having a safety-pin appearance. It is oxidase-
positive, and on culture, the organisms demonstrate different
colony morphology.1 In this case, on Gram stain the pathogen was
observed as scarce Gram-variable bacilli. Culture in blood agar
yielded a small, dry, earth-smelling colony.Isolation of B. pseudomallei from the body ﬂuids of patients
remains the gold standard in the diagnosis and requires the use of
selective media for non-sterile specimens. Gram stain and other
histopathological stains are not speciﬁc for the organism. Skin and
soft tissue infection is a commonmanifestation of melioidosis, and
may result from hematogenous spread and can be the source of
systemic infection. Presentation may be of rapid progression,
similar to necrotizing fasciitis. Bone and joint infections are
uncommon (4–12%) andmay be difﬁcult to diagnose, and systemic
manifestations are prominent. Surgical drainage and long courses
of antibiotics are required.1–5 In our case, the patient developed
sepsis syndrome, which started as osteomyelitis and septic
arthritis.
Currie et al. reported seven cases of septic shock with high
mortality (100%).2 Regarding other non-bacteremic forms, they
reported ﬁve cases of osteomyelitis and septic arthritis with no
mortality (0%). In published series from Thailand and Australia,
other frequent presentations have been suppurative parotitis,
prostatic abscesses, urinary infection and encephalomyelitis
syndrome.3,5
Several randomized, controlled trials have examined intensive
phase interventions in severe melioidosis and are the basis of
ceftazidime-based regimens.1,5 Ceftazidime has been shown to be
of beneﬁt in the treatment of this disease in a sequential open-label
randomized trial of ceftazidime against chloramphenicol–doxycy-
cline–trimethoprim–sulfamethoxazole (known as conventional
therapy) in severe disease, at least for 6 months.1 Other trials have
used amoxicillin–clavulanate and imipenem, granulocyte colony-
stimulating factor (G-CSF) and activated protein C in severe cases
of sepsis.1 For maintenance therapy, amoxicillin–clavulanate vs.
chloramphenicol, doxycycline, trimethoprim–sulfamethoxazole
and ciproﬂoxacin have been recommended, with a duration of
12–20 weeks.1
To our knowledge, this is one of very few cases reported in
South America, raising the alarm for a suspicion of melioidosis in
the differential diagnosis of sepsis in this area and among travelers
coming from this area.
Melioidosis is an extremely rare disease in our country; this is
only the second case reported in Venezuela. Physicians should be
aware of the disease and suspect it in patients coming from rice
plantations.
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